ArcherDx addresses the bottlenecks associated with using next-generation sequencing in translational research by offering a robust platform for targeted sequencing applications.
ArcherDx provides cutting-edge molecular products to laboratories seeking better, genomic answers for cancer.
Their suite of products are highly accurate, personal and easy to use in local settings.
By combining proprietary Anchored Multiplexed PCR (AMP) chemistry and easy-to-use, lyophilized reagents, ArcherDX technology generates highly enriched sequencing libraries to detect gene fusions, SNPs, indels and CNVs. Complemented by the Archer suite of bioinformatics software and readily accessible reports, ArcherDX technology dramatically enhances complex mutation identification and discovery.
For more details on Supplier please visit: http://archerdx.com/
